Page last updated: 2024-08-26

arginyl-glycyl-aspartic acid and Squamous Cell Carcinoma of Head and Neck

arginyl-glycyl-aspartic acid has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, J; Lv, L; Lv, M; Shao, F; Wang, J; Wang, Y; Zheng, Y1

Other Studies

1 other study(ies) available for arginyl-glycyl-aspartic acid and Squamous Cell Carcinoma of Head and Neck

ArticleYear
The anti-tumour activity of rLj-RGD4, an RGD toxin protein from Lampetra japonica, on human laryngeal squamous carcinoma Hep-2 cells in nude mice.
    Biochimie, 2015, Volume: 119

    Topics: Amino Acid Motifs; Angiogenesis Inhibitors; Animals; Apoptosis; Body Weight; Carcinoma, Squamous Cell; Cell Line, Tumor; Fish Proteins; Fish Venoms; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Lampreys; Laryngeal Neoplasms; Marine Toxins; Mice, Nude; Microvessels; Oligopeptides; Random Allocation; Recombinant Proteins; Squamous Cell Carcinoma of Head and Neck; Survival Analysis; Tumor Burden; Xenograft Model Antitumor Assays

2015